Literature DB >> 9176097

Phenotypic and functional characterization of a new human macrophage cell line K1m demonstrating immunophagocytic activity and signalling through HLA class II.

D P Dialynas1, M J Lee, L E Shao, P C Tan, J Yu.   

Abstract

A human macrophage line, designated K1m, has been established from peripheral blood. K1m expresses a number of lineage-specific markers as well as a broad array of intercellular adhesion molecules. In particular, K1m expresses high levels of human leucocyte antigen (HLA) class I and class II. In response to ligation of HLA class II (HLA-DR), but not in response to ligation of HLA class 1, K1m forms tighter homotypic aggregates and develops a striking 'stellate' culture phenotype. K1m also expresses Fc receptors for immunoglobulin G (IgG) (CD64, CD32, and CD16) and can be shown to phagocytose polystyrene latex beads, as well as neuroblastoma cells in the presence of tumour-specific monoclonal antibody (mAb). The K1m cell line should therefore prove useful for studying both signalling through macrophage HLA class II and immunophagocytosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176097      PMCID: PMC1456704          DOI: 10.1046/j.1365-2567.1997.00185.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

Review 1.  Fc gamma R in cytotoxicity exerted by mononuclear cells.

Authors:  M W Fanger; R F Graziano; L Shen; P M Guyre
Journal:  Chem Immunol       Date:  1989

2.  Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay.

Authors:  S E Slezak; P K Horan
Journal:  J Immunol Methods       Date:  1989-02-24       Impact factor: 2.303

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens.

Authors:  R Andreesen; K J Bross; J Osterholz; F Emmrich
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

5.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

6.  Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.

Authors:  K Mujoo; T J Kipps; H M Yang; D A Cheresh; U Wargalla; D J Sander; R A Reisfeld
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

7.  CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes.

Authors:  S B Clarkson; P A Ory
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

8.  Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion.

Authors:  W Mourad; R S Geha; T Chatila
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

9.  Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression.

Authors:  K Mehindate; J Thibodeau; M Dohlsten; T Kalland; R P Sékaly; W Mourad
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.

Authors:  D H Munn; N K Cheung
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  1 in total

1.  Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging.

Authors:  Sandra Santulli-Marotto; Alexis Gervais; Jamie Fisher; Brandy Strake; Carol Anne Ogden; Chelsea Riveley; Jill Giles-Komar
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.